Company description
VYVANSE (lisdexamfetaminedimesylate), a CNS stimulant, is for once-a-day oral administration.The chemical designation for lisdexamfetaminedimesylate is (2S)-2,6-diaminoN-[(1S)-1-methyl-2-phenylethyl] hexanamidedimethanesulfonate. The molecular formula is C15H25N3O•(CH4O3S)2, which corresponds to a molecular weight of 455.60.VYVANSE (lisdexamfetaminedimesylate) Structural Formula IllustrationLisdexamfetaminedimesylate is a white to off-white powder that is soluble in water (792 mg/mL).VYVANSE® is indicated for the treatment of:Attention Deficit Hyperactivity Disorder (ADHD)Moderate to Severe Binge Eating Disorder (BED) in adultsLimitation Of UseVYVANSE is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associatedwith serious cardiovascular adverse events.The safety and effectiveness of VYVANSE for the treatment of obesity have not been established.
